Literature DB >> 21250847

LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies.

Kuldeep Sharma1, Radhe Raman Singh, Murugesh Kandaswamy, Chandan Mithra, Sanjeev Giri, Sriram Rajagopal, Ramesh Mullangi.   

Abstract

An LC-MS/MS-ESI method has been validated for simultaneous estimation of the three endocannabinoids; N-arachidonoylethanolamine (AEA), N-oleoylethanolamine (OEA) and palmitoylethanolamide (PEA), in surrogate matrix using AEA-d (4) as an internal standard with highest sensitivity over the existing methods. Simple precipitation was used to extract analytes and these were subsequently analyzed on a monolithic column. Linear response function was established over the concentration range 12.3 to 1225 pg/ml for AEA (r > 0.994); 0.70 to 641 ng/ml for OEA (r > 0.999) and 0.54 to 321 ng/ml (r > 0.998) for PEA. The intra- and inter-day precision values met the acceptance to criteria as per US FDA guidelines. Analytes were found to be stable in the battery of stability studies. The method was applied to quantify endogenous levels of analytes in rat plasma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21250847     DOI: 10.4155/bio.10.192

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease.

Authors:  Sarah Beggiato; Maria Cristina Tomasini; Tommaso Cassano; Luca Ferraro
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

2.  Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.

Authors:  Stefania Petrosino; Marika Cordaro; Roberta Verde; Aniello Schiano Moriello; Gabriele Marcolongo; Carlo Schievano; Rosalba Siracusa; Fabiana Piscitelli; Alessio F Peritore; Rosalia Crupi; Daniela Impellizzeri; Emanuela Esposito; Salvatore Cuzzocrea; Vincenzo Di Marzo
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.